About
Neurelis, Inc. is a pharmaceutical company developing and commercializing therapies for central nervous system disorders, with a focus on seizure emergencies and epilepsy.
Explore Neurelis, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.